Dopamine and dobutamine have different effects on heart rate variability in patients with congestive heart failure

Chinese Medical Journal (Taipei)

Volumn 61, Issue 4, 1998, Pages 199-209

  Hsueh, Chung Whei ^a,b   Lee, Wen Lieng ^a   Chen, Cheng Kang ^a   Ho, Hung Yun ^a   Chen, Ching Pei ^a   Huang, Jin Long ^a   Huang, Dar San ^a   Chen, Ying Tsung ^a   Ting, Chih Tai ^a  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Dobutamine; Dopamine; Heart failure; Heart rate variability

Indexed keywords

DOBUTAMINE; DOPAMINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ELECTROCARDIOGRAM; FEMALE; HEART RATE VARIABILITY; HUMAN; INOTROPISM; MALE; RANDOMIZED CONTROLLED TRIAL;

AGED; AGED, 80 AND OVER; DOBUTAMINE; DOPAMINE; FEMALE; HEART FAILURE, CONGESTIVE; HEART RATE; HUMANS; MALE; MIDDLE AGED; SYMPATHOMIMETICS;

EID: 0031748587     PISSN: 05781337     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Levine TB, Francis GS, Cohn JN. Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. Am J Cardiol 1981;49:1659-66.
2. Cohn JN, Levine TB, Lura D, Francis GS, Simon AB, Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. New Engl J Med 1984,311:819-23.
3. Binkley PF, Nunziata E, Haas GJ, Nelson SD, Cody RJ. Parasympathetic withdrawal is an integral component of autonomie imbalance in congestive heart failure: demonstration in human subjects and verification in a paced canine model of ventricular failure. J Am Coll Cardiol 1991;18:464-72.
4. Eckberg DL, Drabinsky M, Braunwald E. Defective cardiac parasympathetic control in patients with heart disease. New Engl]Med 1971;285:877-83.
5. Packer M. Modulation of functional capacity and survival in congestive heart failure: effects of activation of the sympathetic nervous system. Postgiad Med 1988;83: 96-103.
6. Swedberg K, Eneroth P, Kjekshus J, Wilhelmsem L, for the CONSENSUS Trial Study Group. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. Circulation 1990;82:1730-6.
7. Remme WJ. Therapeutic strategies and neurohormonal control in heart failure. Em Heart J 1994;15:129-38.
8. Saul JP, Arai Y, Lilly LS, Colucci WS, Cohen RJ. Assessment of autonomie regulation in chronic congestive heart failure by heart rate spectral analysis. Am J Caidiol 1988;61:1292-9.
9. Binkley PF, Cody RJ. Measurement of the autonomie profile in congestive heart failure by spectral analysis of heart rate variability. Heart Failure 1992;8:154-76.
10. Panina G, Khot UN, Nunziata E, Cody RJ, Binkley PF. Assessment of autonomie tone over a 24-hour period in patients with congestive heart failure: relation between mean heart rate and measures of heart rate variability. Am Heart J 1995;129:748-53.
11. Gasolo GC, Stroder D, Sulla A, Chelucci A, Freni A, Zerauschek M. Heart rate variability and functional severity of congestive heart failure secondary to coronary artery disease. Eur Heart J 1995;16:360-7.
12. Panina G, Khot UN, Nunziata E, Cody RJ, Binkley PF. Role of spectral measures of heart rate variability as markers of disease progression in patients with congestive heart failure not treated with angiotensin-converting enzyme inhibitors. Am Heart J 1996;131:153-7.
13. Tuininga YS, Veldhuisen DJ, Brouwer J, Haaksma J, Crijns HJ, Man-in't-veld AJ, Lie KI. Heart rate variability in left ventricular dysfunction and heart failure: effects and implications of drug treatment. Br Heart f 1994,72:509-13.
14. Maliani A, Pagani M, Lombard! F, Cerutti S. Cardiovascular neural regulation explored in the frequency domain. Circulation 1991,84:482-92.
15. Kleiger RE, Stein PK, Bosuer MS, Rottman JN. Time domain measurements of heart rate variability. Caidiol Clin North Am 1992;10:487-98.
16. Pieper SJ, Hammill SC. Heart rate variability: technique and investigational applications in cardiovascular medicine. Mayo Clin Proc 1995;70:955-64.
17. Port JD, Gilbert EM, Larrabee P, Mealey P, Volkman K, Ginsburg R, et al. Neurotransmitter depletion compromises the ability of indirect-acting amines to provide inotropic support in the failing human heart. Circulation 1990;81:929-38.
18. Rajfer SI, Borow KM, Lang RM, Neumann A, Carroll JD. Effects of dopamine on left ventricular afterload and contractile state in heart failure: relation to the activation of beta4adrenergic receptors and dopamine receptors. J Am Coll Cardiol 1988;12:498-506.
19. Goldberg LI, Rajfer SI. Dopamine receptors: applications in clinical cardiology. Circulation 1985,72:245-8.
20. Hollenberg NK, Adams DF, Mendell JL. Renal vascular responses to dopamine. Hemodynamics and angiographie observations in normal man. Clin Sei Mol Med 1973;45: 73342.
21. Vatner SF, Mcritchie RJ, Braunwald E. Effects of dobutamine on left ventricular performance, coronary dynamics, and distribution of cardiac output in conscious dog. J Clin Invest 1974;53:1265-73.
22. Majerus YC, Dasta JF, Bauman JL, Danziger LH, Ruffolo RR Jr. Dobutamine: ten years later. Phatmacotherapy 1989;9:245-59.
23. Anderson FL, Port DJ, Reid BB, Hanson G, Kralios AC, Hershberger RE, Bristow MR. Effects of therapeutic dopamine administration on myocardial catecholamine and neuropeptide Y concentration in the failing ventricles of patients with idiopathic dilated cardiomyopathy. J Cardiovasc Pharmacol 1992;20:800-6.
24. Metra M, Missale C, Spano PF, Cas LD. Dopaminergic drugs in congestive heart failure: hemodynamic and neuroendocrine responses to ibopamine, dopamine, and dihydroergotoxine. J Cardiovasc Pharmacol 1995;25:732-40.
25. Binkley PF, Orsinelli DA, Nunziata E, Patterson SP, Khot UN, Puri R, et al. Differing autonomie response to dobutamine in the presence and absence of ischemia: implications for the autonomie contribution to positive inotropic intervention. Am Heart J 1995;130:1054-61.
26. Hogue CW Jr, Davila-Roman VG, Stein PK, Feinberg M, Lappas DG, Ferez JE. Alterations in heart rate variability in patients undergoing dobutamine stress echocardiography, including patients with neurocardiogenic hypotension. Am Heart /1995;130:1203-9.
27. Brouwer J, van-Veldhuisen DJ, Man-in't-veld AJ, Dunselmann PH, Boomsma F, Haaksma J, Lie KI. Heart rate variability in patients with mild to moderate heart failure: effects of neurohormonal modulation by digoxin and ibopamine. JAm Coll Cardiol 1995;4:983-90.
28. Montano N, Ruscone TG, Porta A, Lombardi F, Pagani M, Malliani A. Power spectrum analysis of heart rate variability to assess the changes in sympathovagal balance during graded orthostatic tilt. Circulation 1994;90:1826-31.
29. Binder T, Frey B, Porenta G, Heinz G, Wutte M, Kleiner G, et al. Prognostic value of heart rate variability in patients awaiting cardiac transplantation. Pace 1992; 15:2215-20.